The startup has developed a non-invasive assessment tool that utilizes advanced optical imaging technology for the early detection and diagnosis of gum disease. This system enhances the speed and accuracy of assessments, enabling timely intervention and improved patient outcomes compared to traditional diagnostic methods.
Funding
$700K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting and diagnosing gum disease can be slow, lack accuracy, and cause discomfort for patients. Traditional tools used by dental professionals may not provide the most efficient or reliable means of assessing periodontal health.
Solution
Periomedic is developing a non-invasive assessment tool that employs advanced optical imaging technology to improve the early detection and diagnosis of gum disease. The system aims to enhance the speed, objectivity, and reproducibility of periodontal assessments, enabling timely intervention and improved patient outcomes. By redesigning clinical tools, Periomedic seeks to provide greater accuracy, simplify real-time data capture, and significantly improve patient comfort during examinations. The company's hardware incorporates a unique system approach intended to become the diagnostic standard for gum disease.
Target Audience
The primary users are dental professionals, including dentists and periodontists, seeking more efficient, accurate, and comfortable methods for assessing gum disease.
Features
- Non-invasive assessment of gum disease
- Advanced optical imaging technology for enhanced detection
- Fast, easy, objective, and reproducible results
- Real-time data capture
- Powerful data analytics
- Real-time control mechanisms